Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type (1 selected)

Type

Guidance programme (7 selected)

Guidance programme

Showing 1 to 3 of 3

Guidance and quality standards in consultation
TitleConsultationTypeConsultation end date
Nivolumab with ipilimumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency [ID1136]Draft guidanceTechnology appraisal guidance
Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinoma [ID2725]Draft guidanceTechnology appraisal guidance
Tarlatamab for previously treated advanced small-cell lung cancer [ID6364]Draft guidanceTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All